Yüklüyor......
Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
OnabotulinumtoxinA has recently been approved by regulatory agencies in the UK and United States for treatment of chronic migraine based on data generated from the PREEMPT studies. As such, onabotulinumtoxinA is the only prophylactic therapy specifically approved for chronic migraine. Most headache...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306767/ https://ncbi.nlm.nih.gov/pubmed/22082429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1526-4610.2011.02022.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|